UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 489

Sortiert nach

Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors

Annals of internal medicine, 2021-01, Vol.174 (1), p.69

2021

Link zum Volltext

Verfügbarkeit prüfen

Challenges of “Return to Work” in an Ongoing Pandemic

The New England journal of medicine, 2020-08, Vol.383 (8), p.779-786

2020

Link zum Volltext

Verfügbarkeit prüfen

Recertification Revisited

Clinical infectious diseases, 2024-05, Vol.78 (5), p.1101-1102

Sax, Paul E

2024

Link zum Volltext

Verfügbarkeit prüfen

Breaking Up Is Hard to Do — More Heartbreak from Corporate Decisions in Medicine

The New England journal of medicine, 2023-11, Vol.389 (19), p.1738-1739

Sax, Paul E.

2023

Link zum Volltext

Verfügbarkeit prüfen

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

The Lancet (British edition), 2017-11, Vol.390 (10107), p.2073-2082

2017

Link zum Volltext

Verfügbarkeit prüfen

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

Clinical infectious diseases, 2020-09, Vol.71 (6), p.1379-1389

2020

Link zum Volltext

Verfügbarkeit prüfen

Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States

PloS one, 2012-02, Vol.7 (2), p.e31591-e31591

2012

Link zum Volltext

Verfügbarkeit prüfen

Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019

Clinical infectious diseases, 2023-02, Vol.76 (4), p.563-572

2023

Link zum Volltext

Verfügbarkeit prüfen

Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e450-e458

2022

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

The Lancet (British edition), 2015-06, Vol.385 (9987), p.2606-2615

2015

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel

JAMA : the journal of the American Medical Association, 2020-10, Vol.324 (16), p.1651

2020

Link zum Volltext

Verfügbarkeit prüfen

Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019

Clinical infectious diseases, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel

JAMA : the journal of the American Medical Association, 2018-07, Vol.320 (4), p.379

2018

Link zum Volltext

Verfügbarkeit prüfen

Personal Stories From a World Turned Upside Down: Introducing the Voices of ID Collection

Clinical infectious diseases, 2024-01, Vol.78 (1), p.3-3

2024

Link zum Volltext

Verfügbarkeit prüfen

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

The Lancet (British edition), 2012-06, Vol.379 (9835), p.2439-2448

2012

Link zum Volltext

Verfügbarkeit prüfen

Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials

Clinical infectious diseases, 2014-05, Vol.58 (9), p.1297-1307

2014

Link zum Volltext

Verfügbarkeit prüfen

Long-term Follow-up After Critical COVID-19: REMAP-CAP Revisited

JAMA : the journal of the American Medical Association, 2023-01, Vol.329 (1), p.25

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV

PloS one, 2020-02, Vol.15 (2), p.e0228847-e0228847

2020

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel

JAMA : the journal of the American Medical Association, 2016-07, Vol.316 (2), p.191

2016

Link zum Volltext

Verfügbarkeit prüfen

The Survival Benefits of AIDS Treatment in the United States

The Journal of infectious diseases, 2006-07, Vol.194 (1), p.11-19

2006

Link zum Volltext

Verfügbarkeit prüfen

EDITORIAL COMMENTARY: Can We Break the Habit of Routine CD4 Monitoring in HIV Care?

Clinical infectious diseases, 2013-05, Vol.56 (9), p.1344-1346

Sax, Paul E.

2013

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel

JAMA : the journal of the American Medical Association, 2023-01, Vol.329 (1), p.63

2023

Link zum Volltext

Verfügbarkeit prüfen

HIV

Infectious disease clinics of North America, 2019-09, Vol.33 (3), p.i-i

2019

Link zum Volltext

Verfügbarkeit prüfen

Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel

JAMA : the journal of the American Medical Association, 2024-03, Vol.331 (12), p.1060

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 489

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(392)
Mit Volltextzugriff
(348)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors

Challenges of “Return to Work” in an Ongoing Pandemic

Recertification Revisited

Breaking Up Is Hard to Do — More Heartbreak from Corporate Decisions in Medicine

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States

Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019

Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel

Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel

Personal Stories From a World Turned Upside Down: Introducing the Voices of ID Collection

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials

Long-term Follow-up After Critical COVID-19: REMAP-CAP Revisited

Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel

The Survival Benefits of AIDS Treatment in the United States

EDITORIAL COMMENTARY: Can We Break the Habit of Routine CD4 Monitoring in HIV Care?

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel

HIV

Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel

Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019

Suchergebnisse filtern